Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
STRYK Brands Inc. is a Canadian health and wellness company formed through the 2026 reverse takeover of Entheon Biomedical Corp. by Nutravisor Inc. The company specializes in a portfolio of nutraceuticals and performance-enhancing products, with a primary focus on its proprietary Nixodine™ pouches, a non-nicotine bio-alternative designed for the smoking cessation and harm reduction markets. STRYK Brands also operates the nootropic brand Leezys and the longevity-focused brand Lifetime Secret. Listed on the Canadian Securities Exchange, the company leverages innovative pouch-based delivery systems to provide on-demand products that support health, performance, and longevity. The firm represents a strategic pivot from Entheon's previous focus on psychedelic-based addiction treatments toward a broader consumer-facing wellness and harm reduction model.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on STRYK Brands.